Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Core Viewpoint - Pfizer projects 2026 revenue between $59.5 billion and $62.5 billion, with adjusted earnings estimated at $2.80 to $3 per share [1] - Wall Street forecasts 2026 revenue at $61.6 billion and adjusted earnings of $3.05 per share [1] Financial Projections - Pfizer's revenue projection for 2026 ranges from $59.5 billion to $62.5 billion [1] - Adjusted earnings per share for Pfizer are expected to be between $2.80 and $3 [1] - Wall Street's revenue forecast for Pfizer in 2026 is $61.6 billion [1] - Wall Street anticipates adjusted earnings per share of $3.05 for Pfizer [1]